Socio-economic status and the effect of guideline-directed medical therapy in the STRONG-HF study

IF 3.7 2区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS ESC Heart Failure Pub Date : 2025-02-12 DOI:10.1002/ehf2.15156
Albertino Damasceno, Hadiza Saidu, Gad Cotter, Beth Davison, Christopher Edwards, Jelena Celutkiene, Marianna Adamo, Mattia Arrigo, Marianela Barros, Jan Biegus, Kamilė Čerlinskaitė-Bajorė, Ovidiu Chioncel, Alain Cohen-Solal, Benjamin Deniau, Rafael Diaz, Gerasimos Filippatos, Etienne Gayat, Antoine Kimmoun, Carolyn S.P. Lam, Marco Metra, Maria Novosadova, Matteo Pagnesi, Peter S. Pang, Piotr Ponikowski, Jozine M. Ter Maaten, Daniela Tomasoni, Adriaan A. Voors, Koji Takagi, Alexandre Mebazaa, Karen Sliwa
{"title":"Socio-economic status and the effect of guideline-directed medical therapy in the STRONG-HF study","authors":"Albertino Damasceno,&nbsp;Hadiza Saidu,&nbsp;Gad Cotter,&nbsp;Beth Davison,&nbsp;Christopher Edwards,&nbsp;Jelena Celutkiene,&nbsp;Marianna Adamo,&nbsp;Mattia Arrigo,&nbsp;Marianela Barros,&nbsp;Jan Biegus,&nbsp;Kamilė Čerlinskaitė-Bajorė,&nbsp;Ovidiu Chioncel,&nbsp;Alain Cohen-Solal,&nbsp;Benjamin Deniau,&nbsp;Rafael Diaz,&nbsp;Gerasimos Filippatos,&nbsp;Etienne Gayat,&nbsp;Antoine Kimmoun,&nbsp;Carolyn S.P. Lam,&nbsp;Marco Metra,&nbsp;Maria Novosadova,&nbsp;Matteo Pagnesi,&nbsp;Peter S. Pang,&nbsp;Piotr Ponikowski,&nbsp;Jozine M. Ter Maaten,&nbsp;Daniela Tomasoni,&nbsp;Adriaan A. Voors,&nbsp;Koji Takagi,&nbsp;Alexandre Mebazaa,&nbsp;Karen Sliwa","doi":"10.1002/ehf2.15156","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Aims</h3>\n \n <p>Acute heart failure (AHF) impacts millions globally, with outcomes varying based on socio-economic status (SES).</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>SES measured by annual household income, years of education and medical insurance coverage. Each patient's income and education level relative to the median or mean, respectively, in the country was calculated, and categorized into tertiles (0, 1 or 2 from lowest to highest). SES scores (0–5) were computed as the sum of these levels plus insurance coverage (0 = <i>no</i> or 1 = <i>yes</i>). Patients' baseline characteristics, outcomes (HF readmission, death and their composite) and the effect of high-intensity care (HIC) vs. usual care (UC) were examined by SES scores 0–2, 3 and 4–5.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Lower SES patients, who were younger, predominantly female, Black and non-European, had fewer comorbidities such as atrial fibrillation, diabetes and ischaemic heart disease and exhibited milder HF, indicated by a lower NYHA class, lower creatinine and higher cholesterol before discharge. Despite having milder HF and less comorbidities, after adjusting for baseline characteristics, patients with higher SES had numerically better outcomes, though differences were not statistically significant. 180-day hazard ratios (HRs) for HF readmission or death were 0.75 (95% CI 0.48–1.16) for SES scores of 3 and 0.85 (95% CI 0.58–1.23) for scores of 4–5, compared to 0–2. Higher SES patients had numerically better treatment effect from HIC, with HRs of 0.69 for SES 0–2, 0.72 for SES 3 and 0.50 for SES 4–5.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>In this post hoc analysis of the STRONG-HF study, lower SES was associated with milder acute HF but similar 180-day outcomes. Higher SES patients benefitted more from HIC.</p>\n </section>\n </div>","PeriodicalId":11864,"journal":{"name":"ESC Heart Failure","volume":"12 3","pages":"1594-1605"},"PeriodicalIF":3.7000,"publicationDate":"2025-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ehf2.15156","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ESC Heart Failure","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ehf2.15156","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Aims

Acute heart failure (AHF) impacts millions globally, with outcomes varying based on socio-economic status (SES).

Methods

SES measured by annual household income, years of education and medical insurance coverage. Each patient's income and education level relative to the median or mean, respectively, in the country was calculated, and categorized into tertiles (0, 1 or 2 from lowest to highest). SES scores (0–5) were computed as the sum of these levels plus insurance coverage (0 = no or 1 = yes). Patients' baseline characteristics, outcomes (HF readmission, death and their composite) and the effect of high-intensity care (HIC) vs. usual care (UC) were examined by SES scores 0–2, 3 and 4–5.

Results

Lower SES patients, who were younger, predominantly female, Black and non-European, had fewer comorbidities such as atrial fibrillation, diabetes and ischaemic heart disease and exhibited milder HF, indicated by a lower NYHA class, lower creatinine and higher cholesterol before discharge. Despite having milder HF and less comorbidities, after adjusting for baseline characteristics, patients with higher SES had numerically better outcomes, though differences were not statistically significant. 180-day hazard ratios (HRs) for HF readmission or death were 0.75 (95% CI 0.48–1.16) for SES scores of 3 and 0.85 (95% CI 0.58–1.23) for scores of 4–5, compared to 0–2. Higher SES patients had numerically better treatment effect from HIC, with HRs of 0.69 for SES 0–2, 0.72 for SES 3 and 0.50 for SES 4–5.

Conclusions

In this post hoc analysis of the STRONG-HF study, lower SES was associated with milder acute HF but similar 180-day outcomes. Higher SES patients benefitted more from HIC.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
STRONG-HF研究中社会经济地位和指导药物治疗的效果
目的:急性心力衰竭(AHF)影响全球数百万人,其结果因社会经济地位(SES)而异。方法:用家庭年收入、受教育年限和医疗保险覆盖率来衡量社会经济地位。计算每个患者相对于该国中位数或平均值的收入和教育水平,并按位数(从低到高依次为0,1或2)进行分类。SES分数(0-5)计算为这些水平加上保险覆盖率的总和(0 =否或1 =是)。通过SES评分0-2、3和4-5检查患者的基线特征、结局(心衰再入院、死亡及其复合)以及高强度护理(HIC)与常规护理(UC)的效果。结果:SES较低的患者年龄较小,主要为女性,黑人和非欧洲人,房颤、糖尿病和缺血性心脏病等合并症较少,出院前NYHA等级较低,肌酐较低,胆固醇较高。尽管心衰较轻,合并症较少,但在调整基线特征后,SES较高的患者在数值上的预后较好,尽管差异无统计学意义。SES评分为3分的HF再入院或死亡的180天风险比(hr)为0.75 (95% CI 0.48-1.16),评分为4-5分的HF再入院或死亡的hr为0.85 (95% CI 0.58-1.23),而SES评分为0-2分的hr为0-2。高SES患者的HIC治疗效果在数值上更好,SES 0-2的hr为0.69,SES 3的hr为0.72,SES 4-5的hr为0.50。结论:在STRONG-HF研究的事后分析中,较低的SES与较轻的急性HF相关,但180天的结果相似。高SES患者从HIC中获益更多。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
ESC Heart Failure
ESC Heart Failure Medicine-Cardiology and Cardiovascular Medicine
CiteScore
7.00
自引率
7.90%
发文量
461
审稿时长
12 weeks
期刊介绍: ESC Heart Failure is the open access journal of the Heart Failure Association of the European Society of Cardiology dedicated to the advancement of knowledge in the field of heart failure. The journal aims to improve the understanding, prevention, investigation and treatment of heart failure. Molecular and cellular biology, pathology, physiology, electrophysiology, pharmacology, as well as the clinical, social and population sciences all form part of the discipline that is heart failure. Accordingly, submission of manuscripts on basic, translational, clinical and population sciences is invited. Original contributions on nursing, care of the elderly, primary care, health economics and other specialist fields related to heart failure are also welcome, as are case reports that highlight interesting aspects of heart failure care and treatment.
期刊最新文献
Issue Information Real-world effectiveness of targeted therapies in ATTR cardiomyopathy: A meta-analysis integrating population-based data Inflammation and genetics in myo-pericardial diseases: Insights from the Italian Study Group on Cardiomyopathies and Pericardial Diseases Economic burden of heart failure in Europe: A systematic review of costs and cost-effectiveness Indirect mitral annuloplasty in patients with reduced or preserved ejection fraction: A real-world, single-centre experience
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1